Atypical haemolytic uraemic syndrome (aHUS) - eculizumab continuing PBS authority application form (PB125)

Use this form for a patient applying for continuing treatment with Pharmaceutical Benefits Scheme (PBS) subsidised eculizumab for aHUS.